Spruce Biosciences (NASDAQ: SPRB) revenue
Spruce Biosciences reported revenue of $0.0m for fiscal 2025, 100.0% less than in fiscal 2024 ($4.9m).
Spruce Biosciences's revenue has fallen for 2 years in a row, and its best year of the last 4 was fiscal 2023. The biggest drop was in fiscal 2024, −51.3%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $0.0m | −100.0% | −$36.5m | — |
| 2024 | $4.9m | −51.3% | −$56.2m | −1,143.4% |
| 2023 | $10.1m | — | −$52.0m | −515.3% |
| 2022 | $0.0m | — | −$47.3m | — |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Spruce Biosciences revenue compared with its sector
By revenue for its latest fiscal year, Spruce Biosciences ranks 418th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Spruce Biosciences, −100.0%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 416th | Revolution Medicines | $0.0m | — |
| 417th | SAB Biotherapeutics | $0.0m | −100.0% |
| 418th | Spruce Biosciences | $0.0m | −100.0% |
| 419th | Scholar Rock | $0.0m | — |
| 420th | Spyre Therapeutics | $0.0m | — |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Spruce Biosciences
- How much revenue did Spruce Biosciences make in fiscal 2025?
- Spruce Biosciences reported revenue of $0.0m for fiscal 2025, compared with $4.9m in fiscal 2024.
- What was the best year for revenue at Spruce Biosciences?
- Of its last 4 fiscal years, fiscal 2023, with $10.1m.
- Where does Spruce Biosciences rank in its sector by revenue?
- It ranks 418th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Spruce Biosciences come from?
- From the annual report (Form 10-K) that Spruce Biosciences files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Spruce Biosciences files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022. More on Spruce Biosciences: the Spruce Biosciences page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.